BlackRock Inc. - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260862. A total of 53 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2023$178,429
+51.4%
301,858
-0.2%
0.00%
Q4 2022$117,891
-28.6%
302,438
-2.2%
0.00%
Q3 2022$165,000
-69.5%
309,311
-9.5%
0.00%
Q2 2022$541,000341,7360.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q2 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 4,500,419$1,754,2630.26%
Virtu Financial LLC 188,075$730.01%
ACADIAN ASSET MANAGEMENT LLC 899,514$3490.00%
Renaissance Technologies 1,208,224$4710.00%
TWO SIGMA SECURITIES, LLC 55,484$21,6280.00%
JPMORGAN CHASE & CO 49,656$190.00%
COMMONWEALTH EQUITY SERVICES, LLC 38,159$140.00%
Gradient Investments LLC 63$250.00%
Allworth Financial LP 1,000$3900.00%
VANGUARD GROUP INC 974,996$380,0530.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders